Hand-out
Press Releases
ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymphoma
Publication follows oral presentation at the American Society of Hematology (ASH) Annual Meeting